Legal Representation
Attorney
Palak Mayani
USPTO Deadlines
Next Deadline
130 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 05, 2025
Extension Available
Until December 05, 2024
Application History
41 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 27, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
May 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 27, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Feb 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 15, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 15, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 13, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 13, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 13, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 13, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jan 13, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Nov 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 11, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 11, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 11, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 11, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
May 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 13, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
May 13, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
May 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 5, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Oct 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 6, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 6, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 6, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 6, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 6, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Aug 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 13, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 13, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 3, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Apr 3, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Apr 3, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Sep 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 26, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use
Class 005
Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer
Class 042
Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials
Class 044
Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories
Classification
International Classes
001
005
042
044